← back to search

David J. Hunter

The University of Sydney · AU
Area of research
Genetics · Oncology
Research interest
Research interests include Cancer Risks and Factors, Genetic Associations and Epidemiology, BRCA gene mutations in cancer, and Nutritional Studies and Diet.
h-index
49
citations
16,436
works
101
NIH funding
primary concept
email

Recent publications

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
EBioMedicine 2025cited by 2position: middledoi
Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries
Nature Genetics 2024cited by 35position: middledoi
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
European Urology 2023cited by 71position: middledoi
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
The American Journal of Human Genetics 2023cited by 23position: middledoi
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
International Journal of Cancer 2020cited by 73position: middledoi
Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
Nature Communications 2019cited by 1position: middledoi
Novel Common Genetic Susceptibility Loci for Colorectal Cancer
JNCI Journal of the National Cancer Institute 2018cited by 190position: middledoi
Body mass index and breast cancer survival: a Mendelian randomization analysis
International Journal of Epidemiology 2017cited by 68position: middledoi
A comprehensive analysis of polymorphic variants in steroid hormone and insulin‐like growth factor‐1 metabolism and risk of <i>in situ</i> breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium
International Journal of Cancer 2017cited by 0position: middledoi
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States
JAMA Oncology 2016cited by 404position: middledoi
Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer
International Journal of Epidemiology 2016cited by 163position: middledoi
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
Oncotarget 2016cited by 112position: middledoi
Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium
Breast Cancer Research and Treatment 2016cited by 22position: middledoi
Characterization of Large Structural Genetic Mosaicism in Human Autosomes
The American Journal of Human Genetics 2015cited by 125position: middledoi
Two susceptibility loci identified for prostate cancer aggressiveness
Nature Communications 2015cited by 102position: middledoi
Association of breast cancer risk <i>loci</i> with breast cancer survival
International Journal of Cancer 2015cited by 31position: middledoi
Genetic risk variants associated with in situ breast cancer
Breast Cancer Research 2015cited by 30position: middledoi
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)
The Prostate 2015cited by 21position: middledoi
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer
PLoS Genetics 2014cited by 36position: middledoi
The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
Cancer Research 2014cited by 32position: middledoi
A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer
PLoS ONE 2014cited by 8position: middledoi
An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population
PLoS ONE 2013cited by 148position: middledoi
Plasma Carotenoid- and Retinol-Weighted Multi-SNP Scores and Risk of Breast Cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Cancer Epidemiology Biomarkers & Prevention 2013cited by 17position: middledoi
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status
Journal of Medical Genetics 2012cited by 68position: middledoi
Genome-wide association study of survival in patients with pancreatic adenocarcinoma
Gut 2012cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Kraft · National Cancer Institute2 papers (2016–2017)Christopher A. Haiman · Mayo Clinic in Arizona2 papers (2016–2017)Sara Lindström · Wayne State University2 papers (2016–2017)Federico Canzian · German Cancer Research Center1 papers (2017–2017)Graham G. Giles · Monash Institute of Medical Research1 papers (2017–2017)Paolo Boffetta · Community Cancer Center1 papers (2016–2016)Susan M. Gapstur · Tiffin University1 papers (2017–2017)Thomas A. Sellers · Oregon Health & Science University1 papers (2016–2016)Signe Borgquist · University of Vermont1 papers (2017–2017)Christopher I. Amos · UNM Comprehensive Cancer Center1 papers (2016–2016)Rudolf Kaaks · Cyprus Institute of Neurology and Genetics1 papers (2017–2017)I‐Min Lee · Harvard University1 papers (2017–2017)Xiaohong R. Yang · Cancer Genetics (United States)1 papers (2017–2017)Kay‐Tee Khaw · MRC Epidemiology Unit1 papers (2017–2017)Roger L. Milne · Monash Institute of Medical Research1 papers (2017–2017)Fredrick R. Schumacher · Case Western Reserve University1 papers (2016–2016)Kyriaki Michailidou · University of Oxford1 papers (2016–2016)Douglas F. Easton · Pacific Biomarkers (United States)1 papers (2016–2016)Loı̈c Le Marchand · The London College1 papers (2017–2017)Regina G. Ziegler · National Institutes of Health1 papers (2017–2017)